Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 963 of 5804
-
Can a smart drug deliver a toxic payload directly to cancer cells?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if ADC drug MC002 works to treat locally advanced/metastatic solid tumors in adults. It will also learn about the safety of MC002. The main questions it aims to answer are: Does participants tolerate the drug MC002 ? What medical probl…
Phase: PHASE1 • Sponsor: Hangzhou MacroLink Biopharmaceutical LLC • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a probiotic fight anal cancer in HIV patients?
Disease control Not yet recruitingThis study is focused on treatment of anal high-grade squamous intraepithelial lesions (HSIL) in persons with HIV (PWH), with the ultimate goal of applying the approach toward prevention of anal cancer in this population
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Heart bypass upgrade: which Artery-Harvesting technique works best?
Disease control Not yet recruitingThe COMFORT Trial is a randomized controlled superiority trial comparing skeletonized (SK) versus non-skeletonized (non-SK) harvesting of the left internal mammary artery (LIMA) to left anterior descending artery (LAD) graft in patients undergoing isolated coronary artery bypass …
Phase: NA • Sponsor: Hamilton Health Sciences Corporation • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a tiny zap during prostate surgery save erectile function?
Knowledge-focused ENROLLING_BY_INVITATIONThis prospective first-in-human feasibility study will evaluate the safety and feasibility of selective electrical stimulation of the neurovascular bundles (NVBs) during nerve-sparing robot-assisted radical prostatectomy (RARP). 20 adult patients with localized prostate cancer, n…
Phase: NA • Sponsor: University Medical Centre Ljubljana • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Can a new oral drug take on hard-to-treat leukaemia?
Disease control Not yet recruitingThe purpose of the study is to assess the safety, pharmacokinetics, and preliminary efficacy of AMX-883 monotherapy in participants with acute myeloid leukaemia (AML) and high-risk myelodysplastic syndrome (MDS) and in combination with anticancer agents in participants with AML.
Phase: PHASE1 • Sponsor: Amphista Therapeutics Ltd • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Simple supplement may cut infection risk after leg fracture surgery
Disease control Not yet recruitingThe objective of this multi-center, prospective, placebo-controlled, randomized study is to compare oral conditionally essential amino acid (CEAA) supplementation for decreasing the key postoperative complications of fracture-related infection, fracture nonunion, and skeletal mus…
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a pill make CAR T-Cell therapy last longer?
Disease control Recruiting nowThis phase I trial tests the safety and effectiveness of pomalidomide after CD19 chimeric antigen receptor T-cell (CD19CART) therapy for the treatment of patients with CD19+ B-cell leukemias or lymphomas that have come back after a period of improvement (relapsed) or do not respo…
Phase: PHASE1 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New implant aims to ease stubborn back pain
Disease control Not yet recruitingThe purpose of this study is to evaluate outcomes in patients treated with iFuse INTRA Ti for chronic SI joint pain.
Sponsor: SI-BONE, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Hope for hand recovery: study tests if Late-Stroke finger movement is possible
Knowledge-focused Not yet recruitingStroke patients with absent voluntary finger extension (VFE) 6-months after stroke are not expected to recover hand function. However, experience from the Queen Square Upper Limb neurorehabilitation service contradicts this view. In this study, we will identify the characteristic…
Phase: NA • Sponsor: University College, London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
New study tests simple behavioral tricks to keep opioid patients in treatment
Disease control Not yet recruitingBuprenorphine, a medication for opioid use disorder (MOUD), is associated with decreased opioid overdose and all-cause mortality. Treatment outcomes improve if patients remain on MOUD for at least six months, a period recommended by expert guidelines, although most studies report…
Phase: NA • Sponsor: Boston University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New CAR T-Cell therapy targets Hard-to-Treat myeloma
Disease control Not yet recruitingThe goal of this study is to evaluate the safety of a new type of CAR T-cell, UF-KURE-BCMA, for the treatment of patients with advanced multiple myeloma that has not responded to other therapies. The main question is whether the use of these new CAR T-cells is safe for patients w…
Phase: PHASE1 • Sponsor: Kure Cells, INC • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New hope for teens with rare nerve disease: drug trial launches
Disease control Not yet recruitingThe main purpose of the study is to determine the correct dose of empasiprubart in adolescent participants. It also aims to evaluate if empasiprubart may work and how safe it is for the use in children living with CIDP. The study consists of an open label treatment phase where p…
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Cutting-Edge DNA sequencing could end diagnostic nightmares for brain disorders
Knowledge-focused Not yet recruitingNucleotide repeats emerge as one of the most prolific classes of genetic variations. They have the propensity to in-crease in length across generations, and have been implicated in at least 65 known neurological/ neurodevelop-mental and neuromuscular conditions. Simultaneous anal…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Scientists map the genetic secrets of a rare brain cancer to pave the way for smarter treatments
Knowledge-focused Not yet recruitingPCNS-DLBCL is a rare extranodal non-Hodgkin lymphoma that primarily affects the brain, spine, or vitreoretinal space. The prognosis for PCNS-DLBCL is significantly worse than that for its systemic counterpart. Understanding how and where this tumor initiates, and how it survives…
Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Gene hunt: could sequencing families unlock the roots of mysterious mental illness?
Knowledge-focused Not yet recruitingAccording to the World Health Organization, one in eight people worldwide has a mental disorder, defined as a significant impairment in thinking, emotional regulation, or behavior. These disorders are classified according to the DSM-5. These psychiatric disorders may be atypical …
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Could a special MRI help doctors better treat pancreatic cancer?
Knowledge-focused Not yet recruitingThis clinical trial tests how well dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) with standard clinical evaluation works to assess treatment response for patients with pancreatic cancer that may be able to be removed by surgery (borderline resectable). Borderline…
Phase: PHASE1, PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
New cell therapy B019 takes on tough lymphoma in first human trial
Disease control Not yet recruitingThe purpose of the study is to evaluate the safety、tolerability and preliminary efficacy of B019 in subjects with relapsed or refractory B-cell non-Hodgkin's lymphoma.
Phase: PHASE1 • Sponsor: Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New scan could sharpen detection of head and neck cancers
Diagnosis Not yet recruitingThis is a prospective study to evaluate the sensitivity and specificity of Cu-64 DOTA-ECL1i PET/CT imaging to serve as a novel precision imaging tool for patients with head and neck squamous cell carcinoma (HNSCC).
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
Can a new pill help men last longer? a trial puts VV913 to the test
Symptom relief Not yet recruitingThis trial adopted a multicenter, randomized, double-blind, placebo-controlled design and consisted of two parts: Part Ⅰ and Part Ⅱ.
Phase: PHASE2 • Sponsor: Vigonvita Life Sciences • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Could a wearable nerve stimulator help MS patients walk more freely?
Symptom relief Not yet recruitingMultiple sclerosis (MS) is a chronic, neurodegenerative disease and the most common cause of non- traumatic disability in young adults. Foot drop, arising from MS-induced muscle weakness, leads to impaired mobility, increased fall risk, reduced overall physical activity and reduc…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC